BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...
Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...
Separately, the company is also studying placing the novel, small-diameter OmniaSecure defibrillation lead in the left bundle branch (LBB) area, which has the potential to enable physiologic pacing to ...
The FDA approved Medtronic’s defibrillator that tailors cardiac resynchronization therapy (CRT) to each patient by using an algorithm to adjust pacing. With its ability to confirm if pulses are ...
The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...
Dr. Ruskin answers the question: 'Treated By Pacemaker Vs. Defibrillator?' — -- Question: What is the difference between abnormal heart rhythms treated by pacemakers and defibrillators? Answer ...
Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.
NICE, FRANCE — Preliminary data suggest cardiac pacing is feasible with implantable cardioverter-defibrillator (ICD) leads placed outside the heart and under the rib cage [1]. Leads were temporarily ...
Criteria to identify appropriate candidates for CRT and CRT-D are based on the experiences gained during clinical trials ( Table II). Trials to date have predominantly included patients with normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback